Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Patient Care and Treatment Strategies for Skin Diseases in Sub-Saharan Africa: Role of Traditional and Western Medicines

Author(s): Astha Sharma*, Sonali Sundaram, Rishabha Malviya*, Swati Verma, Neeraj Kumar Fuloria, Shivkanya Fuloria, Mahendran Sekar, Neelesh Mishra and Dhanalekshmi Unnikrishnan Meenakshi

Volume 23, Issue 3, 2023

Published on: 15 November, 2022

Article ID: e190922208916 Pages: 17

DOI: 10.2174/1871526522666220919105643

Price: $65

Abstract

The perspective of the people of Sub-Saharan Africa (SSA) toward both traditional and western healthcare systems varies. The goal of the current study is to examine the SSA's unique skin disease health care system. This study comprises numerous research that sought to examine how the general public feels about the SSA's current healthcare system. In this review, common skin conditions, such as atopic dermatitis, buruli ulcers, dermatophytosis, and scabies, are addressed. According to this report, government agencies must pay particular attention to skin illnesses in SSA and raise public awareness. Availability of medical care, socioeconomic factors, degree of education, and other factors influence patients’ attitudes toward traditional and western health care differently in different geographic areas. Facts suggest that self-medication is the preference of the majority of patients before seeking dermatological care. The present study concludes that the magnitude of skin diseases is neglected or underestimated in many regions of SSA. Also, western healthcare facilities of many regions of SSA are not up to the mark. The present study recommends that proper access to the health care system and awareness about skin diseases through various government programs can be helpful in the regulation of skin disorders among people of SSA.

Keywords: Skin disease, Sub-Saharan Africa, western health care, traditional medicines, skincare

Graphical Abstract

[1]
Garcia MH, Pence A, Evans J. Africa’s future, Africa’s challenge: Early Childhood Care and Development in Sub-Saharan Africa. Washington DC: Africa Regional Educational Publication: The World Bank 2008.
[http://dx.doi.org/10.1596/978-0-8213-6886-2]
[2]
Mokgobi M. Health Care Practitioners’ Attitudes towards Traditional African Healing. Altern Complement Integr Med (Encinitas) 2016; 3: 1-5.
[3]
Josephine Ozioma EO, Antoinette NCO. Herbal Medicines in African Traditional Medicine. In: Herbal Medicine, Philip F. Builders. London: IntechOpen 2019. Available from: https://www. intechopen.com/chapters/64851
[http://dx.doi.org/10.5772/intechopen.80348]
[4]
Mahomoodally MF. Traditional medicines in Africa: an appraisal of ten potent african medicinal plants. Evid Based Complement Alternat Med 2013; 2013: 1-14.
[http://dx.doi.org/10.1155/2013/617459] [PMID: 24367388]
[5]
Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006; 27(1): 1-93.
[http://dx.doi.org/10.1016/j.mam.2005.07.008] [PMID: 16105678]
[6]
Gurib-Fakim A, Mahomoodally MF. African flora as potential sources of medicinal plants: Towards the chemotherapy of major parasitic and other infectious diseases: A review. Jordan J Biol Sci 2013; 6(2): 77-84.
[http://dx.doi.org/10.12816/0000263]
[7]
Gurib-Fakim A, Brendler T, Phillips LD, Eloff JN. Green Gold: Success stories using southern african medicinal plant species. Association of african medicinal plants standards. 2010.
[8]
Deaton AS, Tortora R. People in sub-Saharan Africa rate their health and health care among the lowest in the world. Health Aff (Millwood) 2015; 34(3): 519-27.
[http://dx.doi.org/10.1377/hlthaff.2014.0798] [PMID: 25715657]
[9]
Steve C. Social support linked to health satisfaction worldwide. Gallup 2012. Available from: https://news.gallup.com/poll/152738/ social-support-linked-health-satisfaction-worldwide.aspx (last accessed on 21 Feb 2021)
[10]
Schwartz PA. Contemporary view of the effect of managed care on the ethics in perinatal medicine. Clin Perinatol 2003; 30(1): 167-80. [viii.
[http://dx.doi.org/10.1016/S0095-5108(02)00092-1] [PMID: 12696794]
[11]
Bvumbwe T, Mtshali N. Nursing education challenges and solutions in Sub Saharan Africa: an integrative review. BMC Nurs 2018; 17(1): 3.
[http://dx.doi.org/10.1186/s12912-018-0272-4] [PMID: 29434521]
[12]
Mokgobi MG. Understanding traditional African healing. African J Phys Heal Educ Recreat Danc 2014; 20 (Suppl. 2): 24-34.
[PMID: 26594664]
[13]
Sodi T, Mudhovozi P, Mashamba T, Radzilani-Makatu M, Takalani J, Mabunda J. Indigenous healing practices in Limpopo Province of South Africa: A qualitative study. Int J Health Promot Educ 2011; 49(3): 101-10.
[http://dx.doi.org/10.1080/14635240.2011.10708216]
[14]
Green EC. Can collaborative programs between biomedical and African indigenous health practitioners succeed? Soc Sci Med 1988; 27(11): 1125-30.
[http://dx.doi.org/10.1016/0277-9536(88)90341-3] [PMID: 3061018]
[15]
Busia K, Kasilo OM. Collaboration between traditional health practitioners and conventional health practitioners: some country experiences. Afr Health Monit 2010; 13: 40-6.
[16]
World Health Organization; Programme on Traditional Medicine Legal status of traditional medicine and complementary/alternative medicine: A worldwide review World Health Organization . 2001. Available from: https://apps.who.int/iris/handle/10665/42452
[17]
Dlamini PS. Facilitating collaboration between traditional healers and western health practitioners in the management of chronic illnesses in Swaziland [dissertation]. South Africa: University of Natal 2001.
[18]
Meissner O. The traditional healer as part of the primary health care team? S Afr Med J 2004; 94(11): 901-2.
[PMID: 15587451]
[19]
Pearce TO. Integrating western orthodox and indigenous medicine. Soc Sci Med 1982; 16(18): 1611-7.
[http://dx.doi.org/10.1016/0277-9536(82)90291-X] [PMID: 7146938]
[20]
World Health Organisation. Declaration of Alma-Ata. International conference on primary health care, Alma-Ata. 1978. [cited 2020 Aug 28]. 1978. Available from: https://www.who.int/publications/ almaata_declaration_en.pdf?ua=1
[21]
Oppong ACK. Healers in transition. Soc Sci Med 1989; 28(6): 605-12.
[http://dx.doi.org/10.1016/0277-9536(89)90255-4] [PMID: 2928836]
[22]
WHO Regional Committee for Africa. Promoting the role of traditional medicine in health systems: a strategy of the African region. Ouagadougou: World Health Organisation Regional Office for Africa. 2000. Available from: https://apps.who.int/iris/handle/ 10665/95467?show=full
[23]
Mokgobi MG. Towards integration of traditional healing and western healing: Is this a remote possibility? Afr J Phys Health Educ Recreation Dance 2013; 2013 (Suppl. 1): 47-57.
[PMID: 26594665]
[24]
Grant M, Haskins L, Gaede B, Horwood C. Bridging the gap: exploring the attitudes and beliefs of nurses and patients about coexisting traditional and biomedical healthcare systems in a rural setting in KwaZulu-Natal. S Afr Fam Pract 2013; 55(2): 175-9.
[http://dx.doi.org/10.1080/20786204.2013.10874329]
[25]
World Health Organisation. Basic documents. 48th ed. Switzertland: World Health Organisation 2014. Available from: https://apps.who.int/iris/handle/10665/151605
[26]
Pretorius E. Traditional and modern medicine working in tandem. Curationis 1991; 14(4): 10-3.
[http://dx.doi.org/10.4102/curationis.v14i4.339] [PMID: 1845633]
[27]
Abegaz BM, Ngadjui BT, Folefoc GN, et al. Prenylated flavonoids, monoterpenoid furanocoumarins and other constituents from the twigs of Dorstenia elliptica (Moraceae). Phytochemistry 2004; 65(2): 221-6.
[http://dx.doi.org/10.1016/j.phytochem.2003.10.028] [PMID: 14732282]
[28]
Elujoba AA. Review of the book “African Herbal Pharmacopoeia” association for African medicinal plants standards. Afr J Tradit Complement Altern Med 2012; 9: 81-2.
[29]
Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica. Phytomedicine 2000; 7(5): 427-48.
[http://dx.doi.org/10.1016/S0944-7113(00)80065-3] [PMID: 11081995]
[30]
Jia Y, Zhao G, Jia J. Preliminary evaluation: The effects of Aloe ferox Miller and Aloe arborescens Miller on wound healing. J Ethnopharmacol 2008; 120(2): 181-9.
[http://dx.doi.org/10.1016/j.jep.2008.08.008] [PMID: 18773950]
[31]
Dlova NC, Ollengo MA. Traditional and ethnobotanical dermatology practices in Africa. Clin Dermatol 2018; 36(3): 353-62.
[http://dx.doi.org/10.1016/j.clindermatol.2018.03.009] [PMID: 29908577]
[32]
Rohra DK, Mustafa OM. Patterns and determinants of self-medication among university students in Saudi Arabia. JPHS 2017; 8: 177-85.
[33]
Brieger W. Roll Back Malaria Pre-testing of Needs Assessment Procedures. Oyo State, Nigeria: IDO Local Government 1998. Available from: http://digicollection.org/hss/es/d/Js2297e/11.html
[34]
Hogewoning A, Amoah A, Bavinck JNB, et al. Skin diseases among school children in Ghana, Gabon, and Rwanda. Int J Dermatol 2013; 52(5): 589-600.
[http://dx.doi.org/10.1111/j.1365-4632.2012.05822.x] [PMID: 23557028]
[35]
Roderick H, Bendeck SE, Chen S, et al. Disease Control Priorities in developing countries: The International Bank for Reconstruction and Development. New York: Oxford University Press 2006; 2: p. 37.
[36]
Schmidt H. Chronic Disease Prevention and Health Promotion.In: Public Health Ethics: Cases Spanning the Globe. Cham: Springer International Publishing 2016; pp. 137-76.
[37]
Khan RB, Hudson MM, Ledet DS, et al. Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study. J Cancer Surviv 2014; 8(4): 688-96.
[http://dx.doi.org/10.1007/s11764-014-0375-1] [PMID: 25008582]
[38]
Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142(5): 931-6.
[http://dx.doi.org/10.1046/j.1365-2133.2000.03473.x] [PMID: 10809850]
[39]
Khatami A, San Sebastian M. Skin disease: A neglected public health problem. Dermatol Clin 2009; 27(2): 99-101. [v.
[http://dx.doi.org/10.1016/j.det.2008.11.011] [PMID: 19254651]
[40]
The University of Manchester. Global Challenges Research Fund (GCRF) PhD studentship programme. Available from: https://www.manchester.ac.uk/study/postgraduate-research/golden/gcrf/ (last accessed on 18 Feb 2021).
[41]
Ezikanyi DN, Sakwari G, Nnamani CV. Aeroallergens in north-central Nigeria. Allergol Immunopathol (Madr) 2018; 46(6): 599-606.
[http://dx.doi.org/10.1016/j.aller.2018.03.008] [PMID: 30055844]
[42]
Stanifer JW, Patel UD, Karia F, et al. The determinants of traditional medicine use in Northern Tanzania: a mixed-methods study. PLoS One 2015; 10(4)e0122638
[http://dx.doi.org/10.1371/journal.pone.0122638] [PMID: 25848762]
[43]
Doe PT, Asiedu A, Acheampong JW, Rowland Payne CME. Skin diseases in Ghana and the UK. Int J Dermatol 2001; 40(5): 323-6.
[http://dx.doi.org/10.1046/j.1365-4362.2001.01229.x] [PMID: 11554993]
[44]
Pratt MM, John K, MacLean AB, Afework S, Phillips DH, Poirier MC. Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. Int J Environ Res Public Health 2011; 8(7): 2675-91.
[http://dx.doi.org/10.3390/ijerph8072675] [PMID: 21845152]
[45]
Mihankhah T, Saeedi M, Karbassi A. Contamination and cancer risk assessment of polycyclic aromatic hydrocarbons (PAHs) in urban dust from different land-uses in the most populated city of Iran. Ecotoxicol Environ Saf 2020; 187109838
[http://dx.doi.org/10.1016/j.ecoenv.2019.109838] [PMID: 31677564]
[46]
Al-Afif KAM, Buraik MA, Buddenkotte J, et al. Understanding the burden of atopic dermatitis in Africa and the middle east. Dermatol Ther (Heidelb) 2019; 9(2): 223-41.
[http://dx.doi.org/10.1007/s13555-019-0285-2] [PMID: 30850961]
[47]
Moto JN, Maingi JM, Nyamache AK. Prevalence of Tinea capitis in school going children from Mathare, informal settlement in Nairobi, Kenya. BMC Res Notes 2015; 8(1): 274.
[http://dx.doi.org/10.1186/s13104-015-1240-7] [PMID: 26116079]
[48]
Sargen MR, Hoffstad O, Margolis DJ. Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) cohort, 2004-2012. J Invest Dermatol 2014; 134(1): 51-7.
[http://dx.doi.org/10.1038/jid.2013.274] [PMID: 23774527]
[49]
Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol 2016; 30(2): 223-49.
[http://dx.doi.org/10.1111/jdv.13301] [PMID: 26449379]
[50]
Sinclair W, Aboobaker J, Jordaan F, Modi D, Todd G. Management of atopic dermatitis in adolescents and adults in South Africa. S Afr Med J 2008; 98(4 Pt 2): 303-19.
[PMID: 18771169]
[51]
Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The role of moisturizers in addressing various kinds of dermatitis: A review. Clin Med Res 2017; 15(3-4): 75-87.
[http://dx.doi.org/10.3121/cmr.2017.1363] [PMID: 29229630]
[52]
Colombo D, Di A. Systemic cyclosporin in the treatment of psoriasis IntechOpen: Rijeka 2012; 2: 1-14.
[http://dx.doi.org/10.5772/27484]
[53]
Kouotou EA, Nansseu JRN, Ngangue Engome AD, Tatah SA, Zoung-Kanyi Bissek AC. Knowledge, attitudes and practices of the medical personnel regarding atopic dermatitis in Yaoundé, Cameroon. BMC Dermatol 2017; 17(1): 1-7.
[http://dx.doi.org/10.1186/s12895-017-0053-x] [PMID: 28209147]
[54]
Neuber K, Schwartz I, Itschert G, Dieck A. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 2000; 143(2): 385-91.
[http://dx.doi.org/10.1046/j.1365-2133.2000.03667.x] [PMID: 10951150]
[55]
Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol 2001; 137(7): 870-3.
[PMID: 11453805]
[56]
Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007; 32(1): 23-7.
[PMID: 17059445]
[57]
Luger T, Van Leent EJM, Graeber M, et al. SDZ ASM 981: An emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001; 144(4): 788-94.
[http://dx.doi.org/10.1046/j.1365-2133.2001.04134.x] [PMID: 11298538]
[58]
Larios G, Alevizos A, Perimeni D, Rigopoulos D, Katsambas A. Rosacea-like demodicidosis. Lancet Infect Dis 2008; 8(12): 804.
[http://dx.doi.org/10.1016/S1473-3099(08)70283-4] [PMID: 19022195]
[59]
Desch C, Nutting WB. Demodex folliculorum (Simon) and D. brevis akbulatova of man: Redescription and reevaluation. J Parasitol 1972; 58(1): 169-77.
[PMID: 5062457]
[60]
Palopoli MF, Fergus DJ, Minot S, et al. Global divergence of the human follicle mite Demodex folliculorum: Persistent associations between host ancestry and mite lineages. Proc Natl Acad Sci USA 2015; 112(52): 15958-63.
[http://dx.doi.org/10.1073/pnas.1512609112] [PMID: 26668374]
[61]
Giselle M, Mariya M. Hair and Scalp Infections.In: Hair Pathology with Trichoscopic Correlations Airstream. Elsevier 2019; pp. 207-18.
[62]
Robert AS. Pediatric Atopic Dermatitis Medication. Medscape. Available from: https://emedicine.medscape.com/article/911574-medication (last accessed on 20 Feb 2021).
[63]
Souissi A, Zeglaoui F, Zouari B, Kamoun MR. A study of skin diseases in Tunis. An analysis of 28,244 dermatological outpatient cases. Acta dermatovenerologicaAlpina, Pannonica. Adriat 2007; 16: 111-6.
[64]
Andrews RM, McCarthy J, Carapetis JR, Currie BJ. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am 2009; 56(6): 1421-40.
[http://dx.doi.org/10.1016/j.pcl.2009.09.002] [PMID: 19962029]
[65]
Aubert H, Barbarot S. Bonne année 2012! Happy new year. Ann Dermatol Venereol 2012; 139: 1.
[http://dx.doi.org/10.1016/j.annder.2011.12.010]
[66]
Conférence de consensus - Prise en charge de la dermatite atopique de l’enfant. Ann Dermatol Venereol 2005; 132(1): 81-91.
[http://dx.doi.org/AD-02-2005-132-1-0151-9638-101019-200511996]
[67]
Ayres PJW, Hooper G. Assessment of the skin penetration properties of different carrier vehicles for topically applied cortisol. Br J Dermatol 1978; 99(3): 307-17.
[http://dx.doi.org/10.1111/j.1365-2133.1978.tb02002.x] [PMID: 708599]
[68]
Fekete E. The pattern of diseases of the skin in the Nigerian guinea savanna. Int J Dermatol 1978; 17(4): 331-8.
[http://dx.doi.org/10.1111/j.1365-4362.1978.tb06087.x] [PMID: 659035]
[69]
Ogunbiyi AO, Daramola OOM, Alese OO. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol 2004; 43(1): 31-6.
[http://dx.doi.org/10.1111/j.1365-4632.2004.01967.x] [PMID: 14693018]
[70]
Rook A, Savin JA, Wilkinson DS. The prevalence, incidence and ecology of diseases of the skin Textbook of Dermatology. Palo Alto: Blackwell Scientific Publications 1986; pp. 39-53.
[71]
Farber EM, Nall L. Psoriasis in the tropics. Epidemiologic, genetic, clinical, and therapeutic aspects. Dermatol Clin 1994; 12(4): 805-16.
[http://dx.doi.org/10.1016/S0733-8635(18)30144-X] [PMID: 7805310]
[72]
Leder R, Farber E. The variable incidence of psoriasis in sub-Saharan Africa. Int J Dermatol 1997; 36(12): 911-9.
[http://dx.doi.org/10.1046/j.1365-4362.1997.00251.x] [PMID: 9466197]
[73]
Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64(2) (Suppl. 2): ii18-23.
[http://dx.doi.org/10.1136/ard.2004.033217] [PMID: 15708928]
[74]
Manzur J, Seboxa T. Skin diseases in Addis Ababa. East Afr Med J 1986; 63(1): 75-80.
[PMID: 3709393]
[75]
Kassi K, Mienwoley OA, Kouyate M, Koui S, Kouassi KA. Severe skin forms of psoriasis in black africans: epidemiological, clinical, and histological aspects related to 56 cases. Autoimmune Dis 2013; 2013: 1-4.
[http://dx.doi.org/10.1155/2013/561032] [PMID: 24490056]
[76]
Ayanlowo O, Akinkugbe A. Clinical pattern of psoriasis in patients seen at a tertiary hospital in Nigeria. J Clin Sci 2018; 13(3): 137-42.
[http://dx.doi.org/10.4103/2468-6859.185251]
[77]
Nnoruka EN. Skin diseases in south-east Nigeria: A current perspective. Int J Dermatol 2005; 44(1): 29-33.
[http://dx.doi.org/10.1111/j.1365-4632.2004.02485.x] [PMID: 15663655]
[78]
Onayemi O, Isezuo SA, Njoku CH. Prevalence of different skin conditions in an outpatients’ setting in north-western Nigeria. Int J Dermatol 2005; 44(1): 7-11.
[http://dx.doi.org/10.1111/j.1365-4632.2004.02298.x] [PMID: 15663650]
[79]
Obasi OE. Psoriasis vulgaris in the Guinea savanah region of Nigeria. Int J Dermatol 1986; 25(3): 181-3.
[http://dx.doi.org/10.1111/j.1365-4362.1986.tb02213.x] [PMID: 3699963]
[80]
Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ. The genetics of psoriasis. Arch Dermatol 1994; 130(2): 216-24.
[http://dx.doi.org/10.1001/archderm.1994.01690020082014] [PMID: 8304761]
[81]
Namazi MR. Why is psoriasis uncommon in Africans? The influence of dietary factors on the expression of psoriasis. Int J Dermatol 2004; 43(5): 391-2.
[http://dx.doi.org/10.1111/j.1365-4632.2004.02126.x] [PMID: 15117377]
[82]
Kassi K, Djeha D, Gbery IP, Kouame K, Sangaré A. Psoriasis in elderly patients in the Côte d’Ivoire: socio-demographic, clinical, and therapeutic aspects, and follow-up. Int J Dermatol 2016; 55(2): e83-6.
[http://dx.doi.org/10.1111/ijd.13138] [PMID: 26517980]
[83]
Yosipovitch G, Tang MBY. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging 2002; 19(11): 847-63.
[http://dx.doi.org/10.2165/00002512-200219110-00003] [PMID: 12428994]
[84]
Wong JW, Koo JYM. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review. Dermatol Res Pract 2012; 2012: 1-4.
[http://dx.doi.org/10.1155/2012/367475] [PMID: 22685455]
[85]
Iannone LF, Bennardo L, Palleria C, et al. Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS One 2020; 15(11)e0241575
[http://dx.doi.org/10.1371/journal.pone.0241575] [PMID: 33141869]
[86]
Dattola A, Silvestri M, Tamburi F, Amoruso GF, Bennardo L, Nisticò SP. Emerging role of anti‐IL23 in the treatment of psoriasis: When humanized is very promising. Dermatol Ther 2020; 33(6)e14504
[http://dx.doi.org/10.1111/dth.14504] [PMID: 33141505]
[87]
Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D. Targeting IL-23 in psoriasis: current perspectives. Psoriasis (Auckl) 2018; 8: 1-5.
[http://dx.doi.org/10.2147/PTT.S98893] [PMID: 29441315]
[88]
"Drug Approval Package: Skyrizi". U.S. Food and Drug Administration (FDA). 30 May 2019. Retrieved 08 October 2020.
[89]
Heukelbach J, Mazigo HD, Ugbomoiko US. Impact of scabies in resource-poor communities. Curr Opin Infect Dis 2013; 26(2): 127-32.
[http://dx.doi.org/10.1097/QCO.0b013e32835e847b] [PMID: 23343887]
[90]
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990 & 2013;2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545-602.
[http://dx.doi.org/10.1016/S0140-6736(16)31678-6] [PMID: 27733282]
[91]
Engelman D, Steer A. Control strategies for scabies. Trop Med Infect Dis 2018; 3(3): 98.
[http://dx.doi.org/10.3390/tropicalmed3030098] [PMID: 30274494]
[92]
Romani L, Tikoduadua L, Kama M, et al. The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: Baseline findings from the skin health intervention Fiji trial. Am J Trop Med Hyg 2017; 97(3): 845-50.
[http://dx.doi.org/10.4269/ajtmh.16-0753] [PMID: 28722612]
[93]
Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health 2018; 54(6): 625-32.
[http://dx.doi.org/10.1111/jpc.13851] [PMID: 29442387]
[94]
Amoako YA, Phillips RO, Arthur J, et al. A scabies outbreak in the North East Region of Ghana: The necessity for prompt intervention. PLoS Negl Trop Dis 2020; 14(12)e0008902
[http://dx.doi.org/10.1371/journal.pntd.0008902] [PMID: 33351803]
[95]
Hay R, Asiedu K. Skin-related neglected tropical diseases (skin NTDs)-A new challenge. Trop Med Infect Dis 2018; 4(1): 4.
[http://dx.doi.org/10.3390/tropicalmed4010004] [PMID: 30585179]
[96]
Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1260-344.
[http://dx.doi.org/10.1016/S0140-6736(17)32130-X] [PMID: 28919118]
[97]
Bowen AC, Mahé A, Hay RJ, et al. The global epidemiology of impetigo: A systematic review of the population prevalence of impetigo and pyoderma. PLoS One 2015; 10(8)e0136789
[http://dx.doi.org/10.1371/journal.pone.0136789] [PMID: 26317533]
[98]
Enbiale W, Ayalew A. Investigation of a scabies outbreak in drought-affected areas in Ethiopia. Trop Med Infect Dis 2018; 3(4): 114.
[http://dx.doi.org/10.3390/tropicalmed3040114] [PMID: 30380650]
[99]
Kouotou EA, Nansseu JRN, Kouawa MK, Zoung-Kanyi Bissek AC. Prevalence and drivers of human scabies among children and adolescents living and studying in Cameroonian boarding schools. Parasit Vectors 2016; 9(1): 400.
[http://dx.doi.org/10.1186/s13071-016-1690-3] [PMID: 27430556]
[100]
Marks M, Sammut T, Cabral MG, et al. The prevalence of scabies, pyoderma and other communicable dermatoses in the Bijagos Archipelago, Guinea-Bissau. PLoS Negl Trop Dis 2019; 13(11)e0007820
[http://dx.doi.org/10.1371/journal.pntd.0007820] [PMID: 31738757]
[101]
Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn’s disease. Gut 1968; 9(1): 17-21.
[http://dx.doi.org/10.1136/gut.9.1.17] [PMID: 5640920]
[102]
Ugbomoiko U, Oyedeji S, Babamale O, Heukelbach J. Scabies in resource-poor communities in nasarawa state, Nigeria: Epidemiology, clinical features and factors associated with infestation. Trop Med Infect Dis 2018; 3(2): 59.
[http://dx.doi.org/10.3390/tropicalmed3020059] [PMID: 30274455]
[103]
Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol 2017; 31(8): 1248-53.
[http://dx.doi.org/10.1111/jdv.14351] [PMID: 28639722]
[104]
Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world–-its prevalence, complications, and management. Clin Microbiol Infect 2012; 18(4): 313-23.
[http://dx.doi.org/10.1111/j.1469-0691.2012.03798.x] [PMID: 22429456]
[105]
Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003; 17(2): 217-25.
[http://dx.doi.org/10.1046/j.1472-8206.2003.00173.x] [PMID: 12667233]
[106]
World Health Organization (WHO) Liberia. Liberia can achieve Universal Health Coverage-Minister of Health. World Health Organisation. 2018. [cited 2020 May 12]. Available from: https://www.afro.who.int/news/liberia-can-achieve-universal-health-coverage-minister-health
[107]
Retsky JE, Kraft C. The extraintestinal manifestations of inflammatory bowel disease Inflammatory Bowel Disease. (4th ed.). Baltimore, Md, USA: Williams & Wilkins 1995; p. 47.
[108]
Quintana C, Galleguillos L, Benavides E, et al. Clinical diagnostic clues in Crohn’s disease: a 41-year experience. ISRN Gastroenterol 2012; 2012: 1-6.
[http://dx.doi.org/10.5402/2012/285475] [PMID: 23213555]
[109]
FitzGerald D, Grainger RJ, Reid A. Interventions for preventing the spread of infestation in close contacts of people with scabies. Cochrane Libr 2014; (2): CD009943
[http://dx.doi.org/10.1002/14651858.CD009943.pub2] [PMID: 24566946]
[110]
Belachew SA, Kassie A. Burden and drivers of Human Scabies among children and adults in Northwestern Ethiopia: The case of the neglected tropical disease. Int J Infect Dis 2018; 73: 317.
[http://dx.doi.org/10.1016/j.ijid.2018.04.4136]
[111]
Wochebo W, Haji Y, Asnake S. Scabies outbreak investigation and risk factors in Kechabira district, Southern Ethiopia: unmatched case control study. BMC Res Notes 2019; 12(1): 305.
[http://dx.doi.org/10.1186/s13104-019-4317-x] [PMID: 31142358]
[112]
Institute JB. The Joanna Briggs institute critical appraisal tools for use in JBI systematic reviews. Checklist for Randomized Controlled Trials 2017. Available from: https://jbi.global/sites/default/ files/2019-05/JBI_RCTs_Appraisal_tool2017_0.pdf
[113]
Etuaful S, Carbonnelle B, Grosset J, et al. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 2005; 49(8): 3182-6.
[http://dx.doi.org/10.1128/AAC.49.8.3182-3186.2005] [PMID: 16048922]
[114]
Portaels F, Agular J, Fissette K, et al. Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 1997; 35(5): 1097-100.
[http://dx.doi.org/10.1128/jcm.35.5.1097-1100.1997] [PMID: 9114387]
[115]
Phillips R, Horsfield C, Kuijper S, et al. Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol 2005; 43(8): 3650-6.
[http://dx.doi.org/10.1128/JCM.43.8.3650-3656.2005] [PMID: 16081892]
[116]
Herbinger KH, Adjei O, Awua-Boateng NY, et al. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 2009; 48(8): 1055-64.
[http://dx.doi.org/10.1086/597398] [PMID: 19275499]
[117]
Phillips RO, Sarfo FS, Osei-Sarpong F, et al. Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 2009; 47(4): 924-6.
[http://dx.doi.org/10.1128/JCM.01842-08] [PMID: 19204098]
[118]
Yu HS, Liao WT, Chai CY. Arsenic carcinogenesis in the skin. J Biomed Sci 2006; 13(5): 657-66.
[http://dx.doi.org/10.1007/s11373-006-9092-8] [PMID: 16807664]
[119]
Anagonou EG, Johnson RC, Barogui YT, et al. Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa). BMC Infect Dis 2019; 19(1): 247.
[http://dx.doi.org/10.1186/s12879-019-3845-2] [PMID: 30871489]
[120]
Havel A, Pattyn SR. Activity of rifampicin on Mycobacterium ulcerans. Ann Soc Belg Med Trop 1975; 55(2): 105-8.
[PMID: 1164050]
[121]
Thangaraj HS, Adjei O, Allen BW, et al. In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. J Antimicrob Chemother 2000; 45(2): 231-3.
[http://dx.doi.org/10.1093/jac/45.2.231] [PMID: 10660507]
[122]
Portaels F, Traore H, De Ridder K, Meyers WM. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother 1998; 42(8): 2070-3.
[http://dx.doi.org/10.1128/AAC.42.8.2070] [PMID: 9687409]
[123]
Renzaho AMN, Woods PV, Ackumey MM, Harvey SK, Kotin J. Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Trop Med Int Health 2007; 12(3): 445-58.
[http://dx.doi.org/10.1111/j.1365-3156.2006.01795.x] [PMID: 17313516]
[124]
Bentoucha A, Robert J, Dega H, Lounis N, Jarlier V, Grosset J. Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother 2001; 45(11): 3109-12.
[http://dx.doi.org/10.1128/AAC.45.11.3109-3112.2001] [PMID: 11600364]
[125]
Dega H, Robert J, Bonnafous P, Jarlier V, Grosset J. Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother 2000; 44(9): 2367-72.
[http://dx.doi.org/10.1128/AAC.44.9.2367-2372.2000] [PMID: 10952581]
[126]
Stanford JL, Phillips I. Rifampicin in experimental Mycobacterium ulcerans infection. J Med Microbiol 1972; 5(1): 39-45.
[http://dx.doi.org/10.1099/00222615-5-1-39] [PMID: 5022508]
[127]
Marsollier L, Honoré N, Legras P, et al. Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob Agents Chemother 2003; 47(4): 1228-32.
[http://dx.doi.org/10.1128/AAC.47.4.1228-1232.2003] [PMID: 12654651]
[128]
Chauty A, Ardant MF, Adeye A, et al. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 2007; 51(11): 4029-35.
[http://dx.doi.org/10.1128/AAC.00175-07] [PMID: 17526760]
[129]
Sarfo FS, Phillips R, Asiedu K, et al. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother 2010; 54(9): 3678-85.
[http://dx.doi.org/10.1128/AAC.00299-10] [PMID: 20566765]
[130]
Vouking MZ, Tamo VC, Tadenfok CN. Clinical efficacy of Rifampicin and Streptomycin in combination against Mycobacterium ulcerans infection: A systematic review. Pan Afr Med J 2013; 15: 155.
[http://dx.doi.org/10.11604/pamj.2013.15.155.2341] [PMID: 24396561]
[131]
Mulder AA, Boerma RP, Barogui Y, et al. Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg 2008; 102(9): 912-20.
[http://dx.doi.org/10.1016/j.trstmh.2008.05.026] [PMID: 18617207]
[132]
Kibadi K. Streptomycin injections for the treatment of Mycobacterium ulcerans (Buruli ulcer) in a rural health zone in the Democratic Republic of the Congo. Sante 2007; 17(3): 173-6.
[PMID: 18180219]
[133]
Johnson RC, Makoutode M, Hougnihin R, et al. Traditional treatment for Buruli ulcer in Benin. Med Trop (Mars) 2004; 64(2): 145-50.
[PMID: 15460142]
[134]
dos Santos MML, Amaral S, Harmen SP, Joseph HM, Fernandes JL, Counahan ML. The prevalence of common skin infections in four districts in Timor-Leste: A cross sectional survey. BMC Infect Dis 2010; 10(1): 61.
[http://dx.doi.org/10.1186/1471-2334-10-61] [PMID: 20219136]
[135]
Komba EV, Mgonda YM. The spectrum of dermatological disorders among primary school children in Dar es Salaam. BMC Public Health 2010; 10(1): 765-70.
[http://dx.doi.org/10.1186/1471-2458-10-765] [PMID: 21162714]
[136]
Zoung-Kanyi Bissek AC. Ntone Ef, Mboua BJ, et al. Clinique et vécu de l’acné chez l’adulte. Health Sci Dis 2008; 9: 46-9.
[137]
Hartshorne ST. Dermatological disorders in Johannesburg, South Africa. Clin Exp Dermatol 2003; 28(6): 661-5.
[http://dx.doi.org/10.1046/j.1365-2230.2003.01417.x] [PMID: 14616837]
[138]
Lehman-Simonet PS. Ulcer: prevention of disability (POD). 2006; 135 Available from: https://www.amazon.com/Buruli-Ulcer-Prevention-Disability-POD/dp/9241546816
[139]
Phillips R. Adjei.; Lucas, S.; Benjamin, N.; Wansbrough-Jones, M. Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides. Antimicrob Agents Chemother 2004; 48: 2866-70.
[http://dx.doi.org/10.1128/AAC.48.8.2866-2870.2004] [PMID: 15273093]
[140]
Phillips R, Kuijper S, Benjamin N, Wansbrough-Jones M, Wilks M, Kolk AHJ. In vitro killing of Mycobacterium ulcerans by acidified nitrite. Antimicrob Agents Chemother 2004; 48(8): 3130-2.
[http://dx.doi.org/10.1128/AAC.48.8.3130-3132.2004] [PMID: 15273132]
[141]
Adjei O, Evans MRW, Asiedu A. Phenytoin in the treatment of Buruli ulcer. Trans R Soc Trop Med Hyg 1998; 92(1): 108-9.
[http://dx.doi.org/10.1016/S0035-9203(98)90977-4] [PMID: 9692170]
[142]
Reid IS. Mycobacterium ulcerans infection: A report of 13 cases at the Port Moresby General Hospital, Papua. Med J Aust 1967; 1(9): 427-31.
[http://dx.doi.org/10.5694/j.1326-5377.1967.tb21363.x] [PMID: 5336860]
[143]
Glynn PJ. The use of surgery and local temperature elevation in Mycobacterium ulcerans infection. Aust N Z J Surg 1972; 41(4): 312-7.
[http://dx.doi.org/10.1111/j.1445-2197.1969.tb06534.x] [PMID: 4260207]
[144]
Meyers WM, Connor DH, Shelly WM. Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg 1974; 23(5): 924-9.
[http://dx.doi.org/10.4269/ajtmh.1974.23.924] [PMID: 4451233]
[145]
Landier J, Boisier P, Fotso Piam F, et al. Adequate wound care and use of bed nets as protective factors against Buruli ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis 2011; 5(11)e1392
[http://dx.doi.org/10.1371/journal.pntd.0001392] [PMID: 22087346]
[146]
Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 2002; 27(2): 138-46.
[http://dx.doi.org/10.1046/j.1365-2230.2002.00997.x] [PMID: 11952708]
[147]
Martin SF, Rustemeyer T, Thyssen JP. Recent advances in understanding and managing contact dermatitis. F1000 Res 2018; 7: F1000.
[http://dx.doi.org/10.12688/f1000research.13499.1] [PMID: 29983912]
[148]
Aujoulat I, Johnson C, Zinsou C, Guédénon A, Portaels F. Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Trop Med Int Health 2003; 8(8): 750-9.
[http://dx.doi.org/10.1046/j.1365-3156.2003.01089.x] [PMID: 12869098]
[149]
El-Khateeb EA, Imam AA, Sallam MA. Pattern of skin diseases in Cairo, Egypt. Int J Dermatol 2011; 50(7): 844-53.
[http://dx.doi.org/10.1111/j.1365-4632.2010.04840.x] [PMID: 21699521]
[150]
Vasudevan B, Joshi DC. Irritant dermatitis to staphylinid beetle in indian troops in Congo. Med J Armed Forces India 2010; 66(2): 121-4.
[http://dx.doi.org/10.1016/S0377-1237(10)80122-4] [PMID: 27375320]
[151]
Zargari O, Kimyai-Asadi A, Fathalikhani F, Panahi M. Paederus dermatitis in northern Iran: A report of 156 cases. Int J Dermatol 2003; 42(8): 608-12.
[http://dx.doi.org/10.1046/j.1365-4362.2003.01771.x] [PMID: 12890103]
[152]
Gnanaraj P, Venugopal V, Mozhi MK, Pandurangan CN. An outbreak of Paederus dermatitis in a suburban hospital in South India: A report of 123 cases and review of literature. J Am Acad Dermatol 2007; 57(2): 297-300.
[http://dx.doi.org/10.1016/j.jaad.2006.10.982] [PMID: 17490784]
[153]
Nelson T, Raitt S. Contact irritant dermatitis in Kenya. J R Army Med Corps 2012; 158(3): 219-20.
[http://dx.doi.org/10.1136/jramc-158-03-14] [PMID: 23472569]
[154]
Kerdel-Vegas F, Goihman-Yahr M. Paederus dermatitis. Arch Dermatol 1966; 94(2): 175-85.
[http://dx.doi.org/10.1001/archderm.1966.01600260067008] [PMID: 5911504]
[155]
Qadir SNR, Raza N, Rahman SB. Paederus dermatitis in Sierra leone. Dermatol Online J 2006; 12(7): 9.
[http://dx.doi.org/10.5070/D38B58K49J] [PMID: 17459295]
[156]
Gelmetti C, Grimalt R. Paederus dermatitis: An easy diagnosable but misdiagnosed eruption. Eur J Pediatr 1993; 152(1): 6-8.
[http://dx.doi.org/10.1007/BF02072506] [PMID: 8444208]
[157]
Uslular C, Kavukçu H, Alptekïn D, et al. An epidemicity of Paederus species in Cukurova region. Cutis 2002; 69(4): 277-9.
[PMID: 12080946]
[158]
Williams AN. Rove beetle blistering-(Nairobi Eye). J R Army Med Corps 1993; 139(1): 17-9.
[http://dx.doi.org/10.1136/jramc-139-01-05] [PMID: 8445591]
[159]
Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46(2)(Suppl Understanding): S98-S106.
[http://dx.doi.org/10.1067/mjd.2002.120791] [PMID: 11807471]
[160]
Diallo S, Thiongane C, Victorius A. Les teignes du cuir cheveluau Senegal oriental: Etude en milieu scolaire a Tambacounda. Med Afr Noire 1985; 32: 495-503.
[161]
Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41(4): 577-80.
[PMID: 10495379]
[162]
Berk T, Scheinfeld N. Seborrheic dermatitis. P&T 2010; 35(6): 348-52.
[PMID: 20592880]
[163]
Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: A comprehensive review. J Dermatolog Treat 2019; 30(2): 158-69.
[http://dx.doi.org/10.1080/09546634.2018.1473554] [PMID: 29737895]
[164]
Ak MA. Comprehensive review of acne vulgaris. J Clin Pharmacol 2019; 1: 17-45.
[165]
Nimma VL, Talla HV, Bairi JK, Gopaldas M, Bathula H, Vangdoth S. Holistic healing through herbs: Effectiveness of aloe vera on post extraction socket healing. J Clin Diagn Res 2017; 11(3): ZC83-6.
[http://dx.doi.org/10.7860/JCDR/2017/21331.9627] [PMID: 28511517]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy